
WY News
Weyerhaeuser Company
$18.90
-$0.07(-0.37%)
44
Overall
80
Value
18
Tech
34
Quality
Market Cap
$13.67B
Volume
8.41M
52W Range
$18.26 - $27.75
Target Price
$28.83
WY news: the latest Weyerhaeuser Company headlines, press releases and market updates, newest first.
Latest WY News
- Bellway (BWY) Gets a Buy from CitiTipRanks Auto-Generated Intelligence Newsdesk · Oct 15, 2026
- Jefferies Sticks to Its Buy Rating for Bellway (BWY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Berenberg Bank Remains a Buy on Bellway (BWY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Percheron Therapeutics seeks ASX quotation for major new share issueTipRanks Australian Auto-Generated Newsdesk · Oct 13, 2026
- Cleanaway Issues New Performance Rights Under Employee Incentive SchemeTipRanks Australian Auto-Generated Newsdesk · Oct 13, 2026
- Cleanaway Reports Lapse of 1.19m Performance Rights on ASXTipRanks Australian Auto-Generated Newsdesk · Oct 12, 2026
- BMO Capital Sticks to Its Buy Rating for Weyerhaeuser (WY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 12, 2026
- ‘History Suggests More Upside Ahead’: Raymond James Picks 2 Stocks to Buy as the Bull Market Rolls OnMichael Marcus · Oct 12, 2026
- Rinova BidCo’s Tender Offer for Reway Group Sees Slow StartTipRanks Italy Auto-Generated Newsdesk · Oct 9, 2026
- Marwynn Holdings signs AI and digital assets MOUTipRanks Auto-Generated Newsdesk · Oct 9, 2026
- Worley Continues Daily On-Market Share Buy-BackTipRanks Australian Auto-Generated Newsdesk · Oct 8, 2026
- Worley cancels over 1.3 million lapsed performance rightsTipRanks Australian Auto-Generated Newsdesk · Oct 8, 2026
- Percheron Grants 75 Million Performance Units to Director Michael BakerTipRanks Australian Auto-Generated Newsdesk · Oct 8, 2026
- Percheron Therapeutics Issues 75 Million Unquoted Performance Stock UnitsTipRanks Australian Auto-Generated Newsdesk · Oct 8, 2026
- Goldman Sachs Sticks to Its Buy Rating for Chewy (CHWY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
- Percheron Therapeutics Wins Strong Shareholder Backing at 2026 AGMTipRanks Australian Auto-Generated Newsdesk · Oct 7, 2026
- Freightways Discloses Former Director Mark Cairns’ Full Exit From ShareholdingTipRanks NewZealand Auto-Generated Newsdesk · Oct 7, 2026
- Worley Director Adjusts Shareholdings as Performance Rights Vest and LapseTipRanks Australian Auto-Generated Newsdesk · Oct 7, 2026
- Worley Seeks ASX Quotation for 1.54 Million New SharesTipRanks Australian Auto-Generated Newsdesk · Oct 7, 2026
- Percheron advances HMBD-002 program as transition year reshapes pipelineTipRanks Australian Auto-Generated Newsdesk · Oct 6, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WY | $18.90 | -0.4% | 8.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |